The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
119535659 11953565 9 F 20160121 20160926 20160126 20160929 EXP ES-JNJFOC-20160119329 JANSSEN 76.79 YR E M Y 82.00000 KG 20160929 MD ES ES

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
119535659 11953565 1 PS DARATUMUMAB DARATUMUMAB 1 Intravenous (not otherwise specified) N 4370774 761036 CONCENTRATE FOR SOLUTION FOR INFUSION
119535659 11953565 2 SS DARATUMUMAB DARATUMUMAB 1 Intravenous (not otherwise specified) 6 TIMES FOR A MONTH, CYCLE 1 DAY 1, 8, 15, 22, 22, 36 N 4370774 100638 1312 MG CONCENTRATE FOR SOLUTION FOR INFUSION
119535659 11953565 3 SS VELCADE BORTEZOMIB 1 Subcutaneous 8 TIMES FOR A MONTH, CYCLE 1 DAY1, 4, 8, 11, 22, 25, 29, 32 N 4371089 0 2.49 MG LYOPHILIZED POWDER
119535659 11953565 4 SS MELPHALAN MELPHALAN 1 Oral 4 TIMES FOR A MONTH 4370783 0 18 MG
119535659 11953565 5 SS DEXAMETHASONE. DEXAMETHASONE 1 Intravenous (not otherwise specified) 0 20 MG
119535659 11953565 6 C ACETYLCYSTEINE. ACETYLCYSTEINE 1 Respiratory (inhalation) D 0 300 MG AEROSOLS TID
119535659 11953565 7 C ONDANSETRON ONDANSETRON 1 Intravenous (not otherwise specified) D 0 8 MG LIQUID TID
119535659 11953565 8 C METFORMIN METFORMIN HYDROCHLORIDE 1 Oral D 0 850 MG TABLET
119535659 11953565 9 C SIMVASTATIN. SIMVASTATIN 1 Oral D 0 10 MG TABLET
119535659 11953565 10 C ENOXAPARIN ENOXAPARIN 1 Subcutaneous D 0 40 MG INJECTION
119535659 11953565 11 C CO-RENITEC ENALAPRILHYDROCHLOROTHIAZIDE 1 D 0
119535659 11953565 12 C ROSUVASTATIN. ROSUVASTATIN 1 D 0
119535659 11953565 13 C OMEPRAZOLE. OMEPRAZOLE 1 D 0
119535659 11953565 14 C ADIRO ASPIRIN 1 D 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
119535659 11953565 2 Plasma cell myeloma
119535659 11953565 3 Plasma cell myeloma
119535659 11953565 4 Plasma cell myeloma
119535659 11953565 5 Plasma cell myeloma
119535659 11953565 6 Spinal cord compression
119535659 11953565 7 Spinal cord compression
119535659 11953565 8 Carbohydrate intolerance
119535659 11953565 9 Spinal cord compression
119535659 11953565 10 Spinal cord compression

Outcome of event

Event ID CASEID OUTC COD
119535659 11953565 LT
119535659 11953565 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
119535659 11953565 Respiratory failure

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
119535659 11953565 2 20151215 0
119535659 11953565 3 20151216 0
119535659 11953565 4 20151216 0
119535659 11953565 5 20151215 0
119535659 11953565 6 20151210 20160126 0
119535659 11953565 7 20151206 20160126 0
119535659 11953565 8 20120925 20160126 0
119535659 11953565 9 20151203 20160126 0
119535659 11953565 10 20151129 20160126 0